Su, Wen <br/><br/>
Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling.  [electronic resource] 

 -  Biochemical and biophysical research communications  Apr 2016 
 - 283-289 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2104 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2016.03.095  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimicrobial Cationic Peptides--chemistry<br/>Blood Platelets--metabolism<br/>Female<br/>Fibrinogen--chemistry<br/>Gene Expression Regulation<br/>Humans<br/>Male<br/>P-Selectin--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation<br/>Platelet Activation--drug effects<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--chemistry<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction<br/>Thrombosis--drug therapy<br/>src-Family Kinases--metabolism<br/>Cathelicidins